Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
PosaconazolePharmacokineticsInvasive CandidiasesInvasive AspergillosisInvasive MycosisFungal InfectionProphylaxis
Interventions
DRUG

Posaconazole pharmacokinetics

Blood samples will be collected on Days 7, 14 and 21 from the onset of Posaconazole prophylactic treatment If significant diarrhoea occurs, additional blood samples will be collected twice weekly until symptoms resolve. All blood samples will be used for Posaconazole pharmacokinetics study.

Trial Locations (1)

3050

RECRUITING

Melbourne Health, Parkville

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Melbourne Health

OTHER

NCT03717623 - Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants | Biotech Hunter | Biotech Hunter